Predictive factors for the efficacy of 131I therapy with formulated dosage calculation on Graves' disease.

Hongbin Zheng, Danyang Sun, Qing Zhang, Qiang Jia, Jian Tan, Jiahui Jin, Zhaowei Meng, Yan Wang, Ke XuPubMed 2022 · DOI

Abstract

Graves' disease patients who are undergoing <sup>131</sup>I therapy using the formulated dosage calculation could be influenced by thyroid mass, thyroid murmurs, <sup>131</sup>I dosage and thyroid function.
BibTeX
@inproceedings{zheng2022predictive,
  author = {Hongbin Zheng and Danyang Sun and Qing Zhang and Qiang Jia and Jian Tan and Jiahui Jin and Zhaowei Meng and Yan Wang and Ke Xu},
  title = {{Predictive factors for the efficacy of <sup>131</sup>I therapy with formulated dosage calculation on Graves' disease.}},
  booktitle = {PubMed},
  year = {2022},
  doi = {10.1967/s002449912470},
}

Loading related content...

Figure